Cargando…

Clinical Outcomes, Costs, and Healthcare Resource Utilization in Patients with Metastatic Merkel Cell Carcinoma Treated with Immune Checkpoint Inhibitors vs Chemotherapy

PURPOSE: Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer with poor prognosis. This study compared patient characteristics, comorbidities, adverse events (AEs), treatment persistence, healthcare resource utilization (HRU) and costs in patients with metastatic MCC (mMCC) treated with imm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Ying, Yu, Ting, Mackey, Rachel H, Gayle, Julie A, Wassel, Christina L, Phatak, Hemant, Kim, Ruth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001053/ https://www.ncbi.nlm.nih.gov/pubmed/33790597 http://dx.doi.org/10.2147/CEOR.S290768

Ejemplares similares

Real‐World Clinical and Economic Outcomes in Selected Immune‐Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors
por: Zheng, Ying, et al.
Publicado: (2021)

Treatment Patterns, Overall Survival, and Total Healthcare Costs of Advanced Merkel Cell Carcinoma in the USA
por: Steuten, Lotte, et al.
Publicado: (2019)

Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma
por: Nghiem, Paul, et al.
Publicado: (2017)

Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US
por: Bharmal, Murtuza, et al.
Publicado: (2019)

Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
por: Lanitis, Tereza, et al.
Publicado: (2019)

A cost‐utility analysis of avelumab for metastatic Merkel cell carcinoma in Taiwan
por: Chang, Wen‐Cheng, et al.
Publicado: (2021)

Real‐world treatment patterns, healthcare resource utilization, and cost among adults with pulmonary arterial hypertension in the United States
por: Pizzicato, Lia N., et al.
Publicado: (2022)

Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
por: Bullement, Ash, et al.
Publicado: (2019)

Quality of Life, Activity Impairment, and Healthcare Resource Utilization Associated with Atrial Fibrillation in the US National Health and Wellness Survey
por: Goren, Amir, et al.
Publicado: (2013)

Travel burden associated with rare cancers: The example of Merkel cell carcinoma
por: Jain, Rahul, et al.
Publicado: (2019)

Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?
por: Zaremba, Anne, et al.
Publicado: (2019)

Primary vs. Secondary Heart Failure Diagnosis: Differences in Clinical Outcomes, Healthcare Resource Utilization and Cost
por: Bueno, Héctor, et al.
Publicado: (2022)

Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma
por: Iyer, Jayasri G., et al.
Publicado: (2016)

Healthcare costs in patients with metastatic lung cancer receiving chemotherapy
por: Vera-Llonch, Montserrat, et al.
Publicado: (2011)

Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs
por: Surrey, Eric, et al.
Publicado: (2020)

Healthcare resource utilization and costs associated with anogenital warts in Morocco
por: Berrada, Myriam, et al.
Publicado: (2021)

Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma
por: Weppler, Alison M, et al.
Publicado: (2020)

An Updated Review of the Biomarkers of Response to Immune Checkpoint Inhibitors in Merkel Cell Carcinoma: Merkel Cell Carcinoma and Immunotherapy
por: Fojnica, Adnan, et al.
Publicado: (2023)

Metastatic Merkel cell carcinoma response to nivolumab
por: Walocko, Frances M., et al.
Publicado: (2016)

Healthcare Resource Utilization and Cost of Invasive Meningococcal Disease in Ontario, Canada
por: Rampakakis, Emmanouil, et al.
Publicado: (2019)

Colorectal cancer-related resource utilization and healthcare costs in Saudi Arabia
por: Balkhi, Bander, et al.
Publicado: (2023)

Is this the end of cytotoxic chemotherapy in Merkel cell carcinoma?
por: Rabinowits, Guilherme
Publicado: (2017)

Liver biochemical flare with immune checkpoint therapy in metastatic Merkel cell carcinoma: A liver biopsy is always necessary
por: Al-Rajhi, Ibrahim, et al.
Publicado: (2021)

The Impact of Adverse Events on Health Care Resource Utilization, Costs, and Mortality Among Patients Treated with Immune Checkpoint Inhibitors
por: George, Saby, et al.
Publicado: (2021)

Outcomes, Healthcare Resource Utilization, and Costs of Overall, Community-Acquired, and Hospital-Acquired Acute Kidney Injury in COVID-19 Patients
por: Koyner, Jay L., et al.
Publicado: (2023)

Treatment Duration, Healthcare Resource Utilization, and Costs Among Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate: A Retrospective Claims Analysis
por: Schultz, Neil M., et al.
Publicado: (2018)

Pattern of healthcare resource utilization and direct costs associated with manic episodes in Spain
por: Tafalla, Monica, et al.
Publicado: (2010)

Healthcare costs and resource utilization of asthma in Germany: a claims data analysis
por: Jacob, Christian, et al.
Publicado: (2015)

Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma
por: Voorham, Jaco, et al.
Publicado: (2018)

Temporal trends in healthcare resource utilization and costs following acute myocardial infarction
por: Shiyovich, Arthur, et al.
Publicado: (2020)

Healthcare Resource Utilization and Costs in Celiac Disease: A US Claims Analysis
por: Cappell, Katherine, et al.
Publicado: (2020)

Healthcare resource utilization and costs among children with cystic fibrosis in the United States
por: Thorat, Teja, et al.
Publicado: (2021)

First-Year Healthcare Resource Utilization Costs of Five Major Cancers in Japan
por: Watanabe, Tomone, et al.
Publicado: (2021)

Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney Disease
por: Blanchette, Christopher M., et al.
Publicado: (2014)

Merkel cell carcinoma metastatic to the small bowel mesentery
por: Matkowskyj, Kristina A., et al.
Publicado: (2011)

Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
por: Walocko, Frances M., et al.
Publicado: (2017)

Challenges of New Approaches in Metastatic Merkel Cell Carcinoma
por: Monteiro, Ana, et al.
Publicado: (2020)

An Extremely Rare Case of Metastatic Merkel Carcinoma of the Liver
por: Thomas, Mathew, et al.
Publicado: (2021)

Avelumab-induced Pneumonitis in Metastatic Merkel Cell Carcinoma
por: Morimoto, Toshiki, et al.
Publicado: (2022)

Merkel Cell Carcinoma: Mind the Genital Metastatic Sites!
por: Santandrea, Giacomo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gspktqi5o5hhim1hn5b3k5t4cf